Sander J. Van Tilburg

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Population Pharmacokinetics and Pharmacodynamics of Immunoglobulins: A Systematic Review.

Population Pharmacokinetics and Pharmacodynamics of Immunoglobulins: A Systematic Review.

Journal: Clinical pharmacokinetics
Published: October 31, 2025

Neurofilament light chain improves clinical prognostic models for Guillain-Barré syndrome.

Neurofilament light chain improves clinical prognostic models for Guillain-Barré syndrome.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: February 18, 2025

If it does not help, it might hurt: Pharmacodynamics of a second IVIg course in Guillain-Barré syndrome.

If it does not help, it might hurt: Pharmacodynamics of a second IVIg course in Guillain-Barré syndrome.

Journal: Annals of clinical and translational neurology
Published: December 24, 2024

Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro: a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases.

Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro: a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases.

Journal: RMD open
Published: December 19, 2024

Genetic variation of low-to-medium-affinity Fc-gamma receptors in Guillain-Barré syndrome.

Genetic variation of low-to-medium-affinity Fc-gamma receptors in Guillain-Barré syndrome.

Journal: Journal of neurology
Published: December 13, 2024

Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome.

Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome.

Journal: EBioMedicine
Published: August 22, 2023

Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study.

Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study.

Journal: Lupus science & medicine
Published: August 08, 2022

Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain-Barré Syndrome.

Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain-Barré Syndrome.

Journal: Clinical pharmacokinetics
Published: May 02, 2022

Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study.

Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study.

Journal: Rheumatology (Oxford, England)
Published: November 05, 2021

Novel approach to monitor intravenous immunoglobulin pharmacokinetics in humans using polymorphic determinants in IgG1 constant domains.

Novel approach to monitor intravenous immunoglobulin pharmacokinetics in humans using polymorphic determinants in IgG1 constant domains.

Journal: European journal of immunology
Published: September 24, 2021

Use of "C9/11 Mismatch" Control siRNA Reveals Sequence-Related Off-Target Effect on Coagulation of an siRNA Targeting Mouse Coagulation Factor XII.

Use of "C9/11 Mismatch" Control siRNA Reveals Sequence-Related Off-Target Effect on Coagulation of an siRNA Targeting Mouse Coagulation Factor XII.

Journal: Nucleic acid therapeutics
Published: May 08, 2019
Showing 1-11 of 11

Last Updated: 09/26/2026